Improved sensitivity of point of care troponin I values using reporting to below the 99th percentile of normals

Clinical Biochemistry

Volumn 46, Issue 12, 2013, Pages 979-982

  Schneider, Hans G ^a,b   Ablitt, Patricia ^a   Taylor, James ^c  

^a Alfred Pathology Service   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Sandringham Hospital   (Australia)

Author keywords

99th percentile; Acute coronary syndrome; Point of care; Troponin

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONVENIENCE SAMPLE; EMERGENCY WARD; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GOLD STANDARD; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBURBAN AREA;

99TH PERCENTILE; ACUTE CORONARY SYNDROME; POINT OF CARE; TROPONIN;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84880617031     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.04.016     Document Type: Article

References (21)

1. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335(18):1342-1349.
2. Wilcox G., Archer P.D., Bailey M., Dziukas L., Lim C.F., Schneider H.G. Measurement of cardiac troponin I levels in the emergency department: predictive value for cardiac and all-cause mortality. Med J Aust 2001, 174(4):170-173.
3. Lam Q., Black M., Youdell O., Spilsbury H., Schneider H.G. Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay. Clin Chem 2006, 52(2):298-300.
4. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361(9):858-867.
5. James S., Flodin M., Johnston N., Lindahl B., Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006, 52(5):832-837.
6. Apple F.S., Jesse R.L., Newby L.K., Wu A.H., Christenson R.H., Cannon C.P., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007, 53(4):547-551.
7. Venge P., Ohberg C., Flodin M., Lindahl B. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. Am Heart J 2010, 160(5):835-841.
8. Jaffe A.S., Apple F.S., Morrow D.A., Lindahl B., Katus H.A. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010, 56(6):941-943.
9. Mingels A., Jacobs L., Michielsen E., Swaanenburg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009, 55(1):101-108.
10. Apple F.S., Murakami M.M. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007, 53(8):1558-1560.
11. Tate J.R., Ferguson W., Bais R., Kostner K., Marwick T., Carter A. The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008, 45(Pt 3):275-288.
12. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361(9):868-877.
13. Bonaca M., Scirica B., Sabatine M., Dalby A., Spinar J., Murphy S.A., et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010, 55(19):2118-2124.
14. Apple F.S., Murakami M.M., Christenson R.H., Campbell J.L., Miller C.J., Hock K.G., et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta 2004, 345(1-2):123-127.
15. Hedberg P., Wennecke G. A preliminary evaluation of the AQT90 FLEX TnI immunoassay. Clin Chem Lab Med 2009, 47(3):376-378.
16. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials & Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials & Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials & Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials & Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol Oct 16 2012, 60(16):1581-1598. [Epub 2012 Sep 5]. 10.1016/j.jacc.2012.08.001.
17. Aldous S.J., Florkowski C.M., Crozier I.G., Elliott J., George P., Lainchbury J.G., et al. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem May 2011, 48(Pt 3):241-248. [Epub 2011 Mar 25].
18. Lee-Lewandrowski E., Januzzi J.L., Grisson R., Mohammed A.A., Lewandrowski G., Lewandrowski K. Evaluation of first-draw whole blood, point-of-care cardiac markers in the context of the universal definition of myocardial infarction: a comparison of a multimarker panel to troponin alone and to testing in the central laboratory. Arch Pathol Lab Med Apr 2011, 135(4):459-463.
19. Kavsak P.A., Worster A. For a rapid diagnosis of acute myocardial infarction, a sensitive troponin assay is needed in the near-patient testing setting. Expert Rev Cardiovasc Ther Mar 2012, 10(3):309-312.
20. Rathore S., Knowles P., Mann A.P., Dodds P.A. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain?. Eur J Intern Med Nov 2008, 19(7):537-540. [Epub 2008 Mar 14].
21. Mills N.L., Churchhouse A.M., Lee K.K., Anand A., Gamble D., Shah A.S., Paterson E., MacLeod M., Graham C., Walker S., Denvir M.A., Fox K.A., Newby D.E. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA Mar 23 2011, 305(12):1210-1216.